 |
 |
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
||
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
|
||||||||||||||||||||||||||
Catalog Number: 20-2903-xx
Description: 3'-CPR II CPG
| 3-(4,4'-Dimethoxytrityloxy)-2,2-(dicarboxymethylamido)propyl- 1-O-succinoyl-long chain alkylamino-CPG | ||
| F.W.: 79.98 | ||
Diluent: Not Applicable |
| Coupling: This support should be used in a manner identical to normal protected nucleoside support since it contains the DMT group. |
| Deprotection: No changes needed from standard method recommended by synthesizer manufacturer. Technical Bulletin |
| Storage: Controlled room temperature or lower, dry |
| Stability in Solution: Not Applicable |
| Please Note: Chemical Phosphorylation Reagent II is covered by US Patent No.: 5,959,090 and European Patent: EP0816368. |
| Catalog Information | Material Safety Data Sheet |
Literature Highlights
| Glen Report 21.1: NEW PRODUCTS - CPR II CPG |
| Glen Report 23.1: Technical Brief - Chemical Phosphorylation Ð considering the options |
01/15/2013 | http://www.glenres.com/ProductFiles/20-2903.html